# Rhythmic Estradiol and Bone Health

> **NCT05903820** · PHASE4 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 48 (actual)

## Conditions studied

- Osteoporosis Risk
- Menopause

## Interventions

- **DRUG:** Estradiol patch
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT05903820
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-19
- **Primary completion:** 2024-10-21
- **Final completion:** 2024-10-28
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05903820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05903820, "Rhythmic Estradiol and Bone Health". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05903820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*